Safety and Tolerability of Low Dose Primaquine

NCT02434952 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Malaria, Falciparum
G6PD Deficiency

Interventions

DRUG: Dihydroartemisinin piperaquine (DHA PP)
DRUG: Primaquine

Sponsor

Malaria Consortium

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]